Move from mom-testing to repeatable pharma customer acquisition

Move from mom-testing to repeatable pharma customer acquisition targets a $1.5B = 5,000 pharma and life-science marketing orgs x $30,000 ACV total addressable market with medium saturation and a year-over-year growth rate of 10% estimated for martech spend in life sciences.

Key trends driving demand: Digital first pharma marketing -- more spend on digital channels increases need for optimization and attribution.; Demand for measurable ROI -- commercial teams are pressured to show revenue impact from campaigns, creating demand for analytics-backed tools.; Consolidation of martech stacks -- customers prefer solutions that integrate into existing CRMs and analytics workflows, raising need for targeted integrations.; Privacy and data constraints -- pharma must navigate stricter compliance, so solutions tailored to these constraints are more adoptable..